Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway

Journal of the American Society of Nephrology

Volumn 18, Issue 1, 2007, Pages 93-102

  He, John Cijiang ^a,b   Lu, Ting Chi ^a   Fleet, Margaret ^c   Sunamoto, Masaaki ^a   Husain, Mohammad ^a   Fang, Wei ^a   Neves, Susana ^a   Chen, Yibang ^a   Shankland, Stuart ^c   Iyengar, Ravi ^a   Klotman, Paul E ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC AMP; ADENOSINE 3',5' PHOSPHOROTHIOATE; ALITRETINOIN; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; FORSKOLIN; MITOGEN ACTIVATED PROTEIN KINASE 1; NEPHRIN; PHOSPHODIESTERASE IV INHIBITOR; PODOCIN; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR ALPHA ANTAGONIST; RETINOID X RECEPTOR; RETINOID X RECEPTOR GAMMA; ROLIPRAM; STAT3 PROTEIN; SYNAPTOPODIN; UNCLASSIFIED DRUG; WT1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GLOMERULOSCLEROSIS; HIV ASSOCIATED NEPHROPATHY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA;

EID: 33845973761     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006070727     Document Type: Article

References (43)

1. Monahan M, Tanji N, Klotman PE: HIV-associated nephropathy: An urban epidemic. Semin Nephrol 21: 394-402, 2001
2. D'Agati V, Appel GB: HIV infection and the kidney. J Am Soc Nephrol 8: 138-152, 1997
3. Barisoni L, Kriz W, Mundel P, D'Agati V: The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 10: 51-61, 1999
4. Barisoni L, Mokrzycki M, Sablay L, Nagata M, Yamase H, Mundel P: Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies. Kidney Int 58: 137-143, 2000
5. Bruggeman LA, Dikman S, Meng C, Quaggin SE, Coffman TM, Klotman PE: Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest 100: 84-92, 1997
6. Bruggeman LA, Ross MD, Tanji N, Cara A, Dikman S, Gordon RE, Burns GC, D'Agati VD, Winston JA, Klotman ME, Klotman PE: Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol 11: 2079-2087, 2000
7. Schwartz EJ, Cara A, Snoeck H, Ross MD, Sunamoto M, Reiser J, Mundel P, Klotman PE: Human immunodeficiency virus-1 induces loss of contact inhibition in podocytes. J Am Soc Nephrol 12: 1677-1684, 2001
8. Husain M, Gusella GL, Klotman ME, Gelman IH, Ross MD, Schwartz EJ, Cara A, Klotman PE: HIV-1 Nef induces proliferation and anchorage-independent growth in podocytes. J Am Soc Nephrol 13: 1806-1815, 2002
9. Sunamoto M, Husain M, He JC, Schwartz E, Klotman PE: Critical role for Nef in HIV-1-induced podocyte dedifferentiation. Kidney Int 64: 1695-1701, 2003
10. He JC, Husain M, Sunamoto M, D'Agati VD, Klotman ME, Iyengar R, Klotman PE: Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways. J Clin Invest 114: 643-651, 2004
11. Evans TR, Kaye SB: Retinoids: Present role and future potential. Br J Cancer 80: 1-8, 1999
12. Vilar J, Gilbert T, Moreau E, Merlet-Benichu C: Metanephros organogenesis is highly stimulated by vitamin A derivatives in organ culture. Kidney Int 49: 1478-1487, 1996
13. Lehrke I, Schaier M, Schade K, Morath C, Waldherr R, Ritz E, Wagner J: Retinoid receptor-specific agonists alleviate experimental glomerulonephritis. Am J Physiol Renal Physiol 282: F741-F751, 2002
14. Wagner J, Dechow C, Morath C, Lehrke I, Amann K, Waldherr R, Floege J, Ritz E: Retinoic acid reduces glomerular injury in a rat model of glomerular damage. J Am Soc Nephrol 11: 1479-1487, 2000
15. Moreno-Manzano V, Mampaso F, Sepulveda-Munoz JC, Alique M, Chen S, Ziyadeh FN, Iglesias-de la Cruz MC, Rodriguez EN, Orellana JM, Reyes P, Arribas I, Xu Q, Kitmura M, Lucio Cazana FJ: Retinoids as a potential treatment for experimental puromycin-induced nephrosis. Br J Pharmacol 139: 823-831, 2003
16. Suzuki A, Ito T, Imai E, Yamato M, Iwatani H, Kawachi H, Hori M: Retinoids regulate the repairing process of the podocytes in puromycin aminonucleoside-induced nephrotic rats. J Am Soc Nephrol 14: 981-991, 2003
17. Allenby G, Bocquel MT, Saunders M, Kazmer S, Speck J, Rosenberger M, Lovey A, Kastner P, Grippo JF, Chambon P, Arthur AL: Retinoic acid receptors and retinoid X receptors: Interactions with endogenous retinoic acids. Proc Natl Acad Sci U S A 90: 30-34, 1993
18. Xu Q, Lucio-Cazana J, Kitamura M, Ruan X, Fine LG, Norman JT: Retinoids in nephrology: Promises and pitfalls. Kidney Int 66: 2119-2131, 2004
19. Gronemeyer H, Miturski R: Molecular mechanisms of retinoid action. Cell Mol Biol Lett 6: 3-52, 2001
20. Benkoussa M, Brand C, Delmotte MH, Formstecher P, Lefebvre P: Retinoic acid receptors inhibit API activation by regulating extracellular signal-regulated kinase and CBP recruitment to an AP1-responsive promoter. Mol Cell Biol 22: 4522-4534, 2002
21. Simonson MS: Anti-AP-1 activity of all-trans retinoic acid in glomerular mesangial cells. Am J Physiol 267: F805-F815, 1994
22. Na SY, Kang BY, Chung SW, Han SJ, Ma X, Trinchieri G, Im SY, Lee JW, Kim TS: Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFkappaB. J Biol Chem 274: 7674-7680, 1999
23. Licht J, Zelent A: Retinoid and growth factor receptor signaling in APL. Blood 105: 1381-1382, 2005
24. Radominska-Pandya A, Chen G, Czernik PJ, Little JM, Samokyszyn VM, Carter CA, Nowak G: Direct interaction of all-trans-retinoic acid with protein kinase C (PKC). Implications for PKC signaling and cancer therapy. J Biol Chem 275: 22324-22330, 2000
25. Hong HY, Varvayanis S, Yen A: Retinoic acid causes MEK-dependent RAF phosphorylation through RARalpha plus RXR activation in HL-60 cells. Differentiation 68: 55-66, 2001
26. Zhao Q, Tao J, Zhu Q, Jia PM, Dou AX, Li X, Cheng F, Waxman S, Chen GQ, Chen SJ, Lanotte M, Chen Z, Tong JH: Rapid induction of cAMP/PKA pathway during retinoic acid-induced acute promyelocytic leukemia cell differentiation. Leukemia 18: 285-292, 2004
27. Parrella E, Gianni M, Cecconi V, Nigro E, Barzago MM, Rambaldi A, Rochette-Egly C, Terao M, Garattini E: Phosphodiesterase IV inhibition by piclamilast potentiates the cytodifferentiating action of retinoids in myeloid leukemia cells. Cross-talk between the cAMP and the retinoic acid signaling pathways. J Biol Chem 279: 42026-42040, 2004
28. Saleem MA, O'Hare MJ, Reiser J, Coward RJ, Inward CD, Farren T, Xing CY, Ni L, Mathieson PW, Mundel P: A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 13: 630-638, 2002
29. Apfel C, Bauer F, Crettaz M, Forni L, Kamber M, Kaufmann P, LeMotte P, Pirson W, Klaus M: A retinoic acid receptor alpha antagonist selectively counteracts retinoic acid effects. Proc Natl Acad Sci U S A 89: 7129-7133, 1992
30. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real time quantitative PCR and the 2-deltadelta CT method. Methods 25: 402-408, 2001
31. Seewaldt V, Kim JH, Caldwell LE, Johnson BS, Swisshelm K, Collins SJ: All-trans-retinoic acid mediates G1 arrest but not apoptosis of normal human mammary epithelial cells. Cell Growth Differ 8: 631-641, 1997
32. Teixeira C, Pratt MA: CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells. Mol Endocrinol 11: 1191-1202, 1997
33. Endlich N, Endlich K: cAMP pathway in podocytes. Microsc Res Tech 57: 228-231, 2002
34. Perez de Lema G, Lucio-Cazana FJ, Molina A, Luckow B, Schmid H, de Wit C, Moreno-Manzano V, Banas B, Mampaso F, Schlondorff D: Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease. Kidney Int 66: 1018-1028, 2004
35. Oseto S, Moriyama T, Kawada N, Nagatoya K, Takeji M, Ando A, Yamamoto T, Imai E, Hori M: Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis. Kidney Int 64: 1241-1252, 2003
36. Vaughan MR, Pippin JW, Griffin SV, Krofft R, Fleet M, Haseley L, Shankland SJ: ATRA induces podocyte differentiation and alters nephrin and podocin expression in vitro and in vivo. Kidney Int 68: 133-144, 2005
37. Bek M, Nusing R, Kowark P, Henger A, Mundel P, Pavenstadt H: Characterization of prostanoid receptors in podocytes. J Am Soc Nephrol 10: 2084-2093, 1999
38. Endlich N, Nobiling R, Kriz W, Endlich K: Expression and signaling of parathyroid hormone-related protein in cultured podocytes. Exp Nephrol 9: 436-443, 2001
39. Aronica SM, Lee Kraus W, Katzenellenbogen BS: Estrogen action via the cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci U S A 91: 8517-8521, 1994
40. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER: A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307: 1572-1573, 2005
41. Husain M, D'Agati V, He JC, Klotman ME, Klotman PE: HIV-1 Nef induces dedifferentiation of podocytes in vivo: A characteristic feature of HIVAN. AIDS 19: 1975-1980, 2005
42. Xu Q, Konta T, Furusu A, Nakayama K, Lucio-Cazana J, Fine LG, Kitamura M: Transcriptional induction of mitogen-activated protein kinase phosphatase 1 by retinoids: Selective roles of nuclear receptors and contribution to the antiapoptotic effect. J Biol Chem 277: 41693-41700, 2002
43. Dong S, Chen SJ, Tweardy DJ: Cross-talk between retinoic acid and STAT3 signaling pathways in acute promyelocytic leukemia. Leuk Lymphoma 44: 2023-2029, 2003